Oscar Health Inc (NYSE:OSCR)’s traded shares stood at 0.62 million during the latest session, with the company’s beta value hitting 1.72. At the last check today, the stock’s price was $11.74, to imply a decrease of -4.16% or -$0.51 in intraday trading. The OSCR share’s 52-week high remains $23.79, putting it -102.64% down since that peak but still an impressive 2.3% since price per share fell to its 52-week low of $11.47. The company has a valuation of $2.94B, with an average of 4.94 million shares in intraday trading volume over the past 10 days and average of 4.82 million shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Oscar Health Inc (OSCR), translating to a mean rating of 2.62. Of 5 analyst(s) looking at the stock, 0 analyst(s) give OSCR a Sell rating. 0 of those analysts rate the stock as Overweight while 2 advise Hold as 3 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at 0.81.
Oscar Health Inc (NYSE:OSCR) trade information
After registering a -4.16% downside in the latest session, Oscar Health Inc (OSCR) has traded red over the past five days. The 5-day price performance for the stock is -9.69%, and -8.85% over 30 days. With these gigs, the year-to-date price performance is -12.65%. Short interest in Oscar Health Inc (NYSE:OSCR) saw shorts transact 21.13 million shares and set a 3.48 days time to cover.
The extremes give us $5 and $28 for target low and target high price respectively. As such, OSCR has been trading -138.5% off suggested target high and 57.41% from its likely low.
Oscar Health Inc (OSCR) estimates and forecasts
The rating firms project that company’s revenue will grow 21.66% compared to the previous financial year.
Revenue forecast for the current quarter as set by 7 analysts is 2.87B. Meanwhile, for the current quarter, a total of 7 analyst(s) estimate revenue growth to 2.78B.Earnings reports from the last fiscal year show that sales brought in 2.14B and 2.22B respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 33.75% before jumping 25.19% in the following quarter.
OSCR Dividends
Oscar Health Inc has its next earnings report out on 2025-Feb-03. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Oscar Health Inc (NYSE:OSCR)’s Major holders
Oscar Health Inc insiders hold 3.32% of total outstanding shares, with institutional holders owning 92.11% of the shares at 95.28% float percentage. In total, 92.11% institutions holds shares in the company, led by VANGUARD GROUP INC. As of 2024-06-30, the company held over 17.38 million shares (or 7.5114% of shares), all amounting to roughly $275.03 million.
The next major institution holding the largest number of shares is BLACKROCK INC. with 14.18 million shares, or about 5.9391% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $224.25 million.
We also have VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and SMALLCAP WORLD FUND INC as the top two Mutual Funds with the largest holdings of the Oscar Health Inc (OSCR) shares. Going by data provided on Dec 31, 2024 , VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund holds roughly 6.14 shares. This is just over 2.85% of the total shares, with a market valuation of $72.0 million. Data from the same date shows that the other fund manager holds a little less at 5.25, or 2.44% of the shares, all valued at about 61.55 million.
